Reckitt Benckiser Group plc (RBGPF)
| Market Cap | 40.08B -9.7% |
| Revenue (ttm) | 19.12B -0.9% |
| Net Income | 4.28B +106.1% |
| EPS | 6.55 +116.1% |
| Shares Out | n/a |
| PE Ratio | 9.36 |
| Forward PE | 13.82 |
| Dividend | 1.17 (1.86%) |
| Ex-Dividend Date | Aug 7, 2025 |
| Volume | n/a |
| Average Volume | 1,489 |
| Open | 63.18 |
| Previous Close | 64.70 |
| Day's Range | 63.18 - 63.18 |
| 52-Week Range | 62.60 - 90.71 |
| Beta | 0.30 |
| RSI | 36.99 |
| Earnings Date | Jul 29, 2026 |
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under... [Read more]
Financial Performance
In 2025, Reckitt Benckiser Group's revenue was 14.21 billion, an increase of 0.25% compared to the previous year's 14.17 billion. Earnings were 3.18 billion, an increase of 123.14%.
Financial numbers in GBP Financial StatementsNews
Reckitt stock dips on Q1 miss: what's really ailing the health giant?
Reckitt stock fell about 5% in early trading on Wednesday after the consumer goods group said first-quarter core like-for-like net revenue rose only 1.3%. The figure was well below the 2.9% analysts h...
Reckitt's Like-for-Like Revenue Rises on Emerging Markets Performance
Lysol maker Reckitt Benckiser booked a rise in first-quarter like for like revenue, helped by strong emerging markets performance, where like-for-like sales grew 7.6%.
Reckitt misses revenue forecast, warns on margins on oil price shock
Reckitt missed quarterly like-for-like revenue forecasts and warned of lower first-half margins, citing high oil prices and a weak cold and flu season, knocking the Dettol maker's shares as much as 7...
Lysol Maker Reckitt Books Rise in Revenue, Boosted by Emerging Markets
The Lysol disinfectant maker's sales grew 5% on a like-for-like basis on year, Reckitt Benckiser said.
Avatars, influencers in China livestreams help drive Reckitt's emerging-market led growth
Influencers and AI-generated avatars selling everything from Durex condoms to Harpic toilet cleaner on livestreaming apps in China are propelling emerging-market led growth for consumer goods company ...
Reckitt Benckiser Logs Higher Sales as Consumers Spend on Self-Care
Sales grew 7% on a like-for-like basis, lifted by consumer spending on self-care, germ-protection and sexual-health products.
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 4, 2025 in Reckitt Benckiser Group plc Lawsuit – RBGLY
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Reckitt Benckiser Group plc (OTCQX: RBGLY).
Metaguest.AI Begins Trading on OTCQB Venture Market, Provides Financing Update, and Announces Investor Forum on August 7
TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Metaguest.AI Incorporated (CSE: METG) (OTCQB:MGSTF) (“Metaguest” or the “Company”) an AI technology company transforming the hospitality sector through intel...
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo...
President Trump demands drugmakers slash prices within 60 days
CNBC's Joe Kernen reports on the latest news.
Reckitt Benckiser stock jumps 10% on profit beat, upgraded outlook
Reckitt Benckiser shares surged on Thursday after the consumer-goods company reported better-than-expected performance in its core business, beat profit forecasts, and raised its full-year outlook, si...
Reckitt sells Essential Home stake to Advent for $4.8 billion
Reckitt has sold a majority stake in its Essential Home business to private equity firm Advent International in a deal valued at $4.8 billion including debt, it said on Friday.
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 4, 2025 in Reckitt Benckiser Group plc Lawsuit - RBGLY
NEW YORK , July 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Reckitt Benckiser Group plc (OTC PINK: RBGLY). Shareholders who purchased shares of RBGLY duri...
Exclusive: Reckitt talks exclusively to Advent on Essential Home sale, sources say
Britain's Reckitt is talking exclusively to private equity firm Advent International over a sale of the consumer goods group's Essential Home business, two sources with direct knowledge of the matter ...
Reckitt eyes new options to advance Air Wick unit sale, sources say
Britain's Reckitt is considering new options to advance a sale of its Essential Home business, home to Air Wick fresheners and Cillit Bang cleaners, after bids came in below expectations, two people w...
US judge allows testimony that Abbott and Mead Johnson preterm baby formula caused deadly disease
A federal judge on Friday said she will allow expert testimony that formula made by Abbott Laboratories and Reckitt Benckiser subsidiary Mead Johnson for premature babies can cause a fatal intestinal ...
National Advertising Division Finds Certain Lysol Air Sanitizer Claims Supported; Recommends Reckitt Discontinue Certain Odor Elimination Claims
In a challenge brought by The Procter & Gamble Company (P&G), BBB National Programs' National Advertising Division has found certain express and implied claims made by Reckitt Benckiser LLC supported,...
Lysol Maker Reckitt Confident of Mitigating Tariff Impact
The Lysol maker confirmed its 2025 guidance as it reported comparable sales growth for the first quarter.
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Current Investigation Into Reckitt Benckiser Group PLC (OTC: RBGLY)
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Reckitt Benckiser Group PLC (...
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Ongoing Investigation Into Reckitt Benckiser Group PLC (OTC: RBGLY)
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Reckitt Benckiser Group PLC (...
Reckitt says US court grants new trial in preterm formula case
Reckitt said on Friday a circuit court in the United States had ruled that a new trial could be sought by plaintiffs in a case that accused the London-listed firm and Abbott of failing to warn of the ...
Reckitt misses fourth-quarter sales expectations
Reckitt , the maker of Dettol cleaning products and Strepsils throat lozenges, missed expectations for fourth-quarter like-for-like net sales, posting on Thursday a 4.6% rise.
The Schall Law Firm Invites Shareholders With Losses In Reckitt Benckiser Group plc To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reckitt Benc...